Coronary Artery Disease

Patients presenting with STEMI who do not have standard modifiable CV risk factors are at elevated risk for all-cause mortality, according to results published in The Lancet.

Optimal clopidogrel dose in MI with no obstructive coronary arteries (MINOCA) vs. MI with obstructive CAD.

Shockwave Medical announced its intravascular lithotripsy system received premarket approval from the FDA for the treatment of calcified CAD.

Patients with MI with nonobstructive coronary arteries, or MINOCA, have fewer recurrent events than those with MI and obstructive CAD, but double-dose clopidogrel was more harmful in MINOCA, according to CURRENT-OASIS 7 trial data.

A recent randomized clinical trial showed how a modified Mediterranean diet provided additional cardiometabolic benefits besides those obtained with the conventional Mediterranean diet. It was the top story in cardiology last week.

Patients with premature CAD had frequent ischemic recurrences and a high proportion of modifiable CV risk factors, and often died young, researchers reported.

Prognostic value and therapeutic potential of flow and pressure measurements to assess coronary artery stenosis.

In the general Swedish population, 4 in 10 middle-aged adults have silent CAD and 1 in 20 have severe CAD on coronary CT angiography, according to new data from the Swedish Cardiopulmonary Bioimage Study.

With advances across multiple imaging modalities, decision-making regarding the optimal test for the evaluation of CAD can be challenging. However, the role of coronary CT angiography has become more important in the wake of recent trials.

In the past year, numerous drugs and interventions have addressed diabetes, obesity, and cardiometabolic health, according to presentations at the virtual Cardiometabolic Health Congress.